Abu Dhabi, United Arab Emirates: Sheikh Shakhbout Medical City (SSMC), one of the UAE’s largest hospitals for serious and complex care and a joint-venture partnership between Abu Dhabi Health Services Company (SEHA) and Mayo Clinic, has officially launched its comprehensive center for Inflammatory Bowel Disease (IBD). The new facility is unique in the UAE, offering differentiated care, and set to become the preeminent destination for IBD medical care in the region. 

As part of its set of services, the SSMC IBD Center has onboarded a new dedicated, multidisciplinary team of experts that will be delivering surgical, endoscopic, nutritional, radiological, pharmaceutical, and eventually behavioral health services, amongst others.

Dr. Talha Malik, SSMC’s new director for the SSMC IBD Center, said: “Our aim is to keep our approach to IBD care patient-centric and comprehensive; creating a one-stop-shop for IBD care that caters to our patient’s specific treatment requirements.”

The SSMC IBD Center staffs a team of specialized colorectal surgeons who offer the full gamut of surgical procedures including minimally invasive and robotic surgery. This approach has a significant impact on patient outcomes, reducing the risk of complications, pregnancy and fertility issues as well as improving future bowel function.

Dr. Faek El Jamali, division chair of Colorectal Surgery, SSMC, said: “The close cooperation between gastroenterology and colorectal surgery specialists is an essential aspect of the comprehensive and patient centered care that we aim to provide at the newly established SSMC IBD center. IBD is a unique and challenging disease. Patients benefit the most when they are seen and managed by a collaborative team of specialists from the outset to select the most appropriate treatment plan for every individual patient. If a decision for surgery is made, we are proud to offer the most advanced surgical procedures using minimally invasive and robotic assisted techniques to minimize surgical impact and improve outcomes.” 

Dr. Michael Wallace, Gastroenterology and Hepatology consultant and division chair, SSMC, adds: “The endoscopic options provided by our center are also valuable. IBD patients are at significantly greater risk of pre-cancerous lesions of the colon which are typically difficult to see and remove. We specialize in advanced methods of detection such as chromoendscopy (both digital and blue-dye) and the removal of these through endoscopes as opposed to surgery. We have already received patients who have been referred to us for surgery, but we can offer them a non-surgical removal of those lesions.”

A rarely available procedure at other UAE facilities is chromo colonoscopy, which is an area of expertise offered by the SSMC IBD Center. Chromo colonoscopy, or chromoendoscopy, is an adjunctive procedure which refers to the application of topical dying or digital optical filters during an endoscopy in order to identify otherwise difficult to see abnormalities. 

While every avenue is investigated in order to avoid invasive procedures, if surgery is required, the team also includes three dedicated subspecialty-trained colorectal surgical specialists.

Dr. Talha Malik said: “In addition to our innovative and holistic approach, we’re actively seeking to create the first IBD consortium in Abu Dhabi. This registry will encompass every IBD patient in the emirate and will enable us to conduct robust observational research and put into place a clinical trials infrastructure that directly aims to address the needs of our local IBD patients.”

Another marked benefit for SSMC IBD patients will be their access to gender-preferred care. As part of SSMC’s ‘Where Women Take Care of Women’’ campaign that ran during Colorectal Cancer Awareness Month, SSMC’s female endoscopists and colorectal surgeon spearheaded the practice of colonoscopies and colorectal care for female patients, offering reassurance and ‘comfortability’ as a means to increase participation in endoscopic screening.

A unique feature of our destination medical center is comprehensive, integrated and holistic care. As such, we provide all key services, including medical, surgical as well as nutritional, advanced radiology, laboratory testing, ostomy care, and pharmacy under one roof in our modern state of the art facility.

Dr. Michael Wallace, concludes: “With SSMC and Mayo Clinic’s collaborative, patient-centric approach, we’re in a position to draw from the strengths of our joint venture partnership, leveraging the learnings and successes we have had at our Mayo Clinic IBD centers internationally. Our doors are open. Anyone who comes to us with IBD, we’re ready to care for them.”

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.